Mygdalon (Metoclopramide Hydrochloride Bp)

Metoclopramide Hydrochloride, the active ingredient in Mygdalon, is a dopamine antagonist presented as an oral formulation for oral use. It treats nausea and vomiting, gastroparesis, gastro‑oesophageal reflux disease and helps prevent chemotherapy‑induced nausea in adult patients.

GNH USA supplies Mygdalon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage conditions that involve impaired gastrointestinal motility and nausea. - Nausea and vomiting: reduces episodes in postoperative, migraine and other acute settings. - Gastroparesis: improves gastric emptying and relieves related symptoms. - Gastro‑oesophageal reflux disease (GERD): decreases reflux episodes and associated discomfort. - Prevention of chemotherapy‑induced nausea: lowers incidence and severity of nausea during cancer treatment.

Metoclopramide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: agitation or inability to stay still. - Diarrhea: loose or watery stools. - Dry mouth: reduced salivation leading to a dry feeling.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements, often of the face. - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Seizures: sudden, uncontrolled electrical activity in the brain. - Severe allergic reaction: rash, swelling, difficulty breathing.

Before prescribing Mygdalon, clinicians should consider several safety factors. - Renal or hepatic impairment: adjust use and monitor function. - Extrapyramidal symptoms: watch for muscle rigidity or tremor. - Depression or suicidal thoughts: use with caution. - Known hypersensitivity: avoid if allergic to metoclopramide. - Elderly patients: start at lower dose and monitor closely. - Store at room temperature: keep in the original pack, protect from moisture.

Metoclopramide can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antipsychotics: increased risk of extrapyramidal effects. - CYP2D6 inhibitors: elevated metoclopramide plasma levels. - MAO inhibitors: potential hypertensive crisis.

Moderate Interactions (Monitor Closely): - Anticholinergics: may reduce pro‑kinetic efficacy. - SSRIs: risk of serotonin syndrome. - Alcohol: enhanced central nervous system depression.